Table 5 Operative details in patients undergoing LVAD implantation at UAB, 2017–2020
From: Preoperative hemodynamics as predictors of right heart failure post-left ventricular assist device
Operative details | Overall (n = 114) | RHF (n = 70) | No RHF (n = 44) | p-value |
|---|---|---|---|---|
Aortic valve procedure | 3 (2.8%) | 2 (3.0%) | 1 (2.4%) | 0.8413 |
Tricuspid valve procedure | 11 (10.2%) | 7 (10.6%) | 4 (9.5%) | 0.8561 |
Procedure time (as defined skin-to-skin time), min | 307.3 ± 103.6 | 315.8 ± 104.1 | 294.0 ± 102.5 | 0.2865 |
Cardiopulmonary bypass time (minutes) | 121.4 ± 44.0 | 123.7 ± 43.1 | 117.8 ± 45.6 | 0.4998 |
Lowest intra-op hematocrit (%) | 25.1 ± 4.2 | 25.3 ± 4.4 | 24.7 ± 3.9 | 0.4136 |
Intraoperative transfusion | 104 (97.2%) | 64 (97.0%) | 40 (97.6%) | 0.8571 |
Intraoperative use of IABP pre-induction | 73 (67.6%) | 44 (66.7%) | 29 (69.0%) | 0.7966 |
HeartMate 3 | 22 (19.3%) | 12 (17.1%) | 10 (22.7%) | 0.4620 |
HVAD | 78 (68.4%) | 49 (70.0%) | 29 (65.9%) | 0.6473 |
HeartMate 2 | 14 (12.3%) | 9 (12.9%) | 5 (11.4%) | 0.8130 |